Published 2018 | Version v1
Journal article

Vitamins E and C Prevent DNA Double-strand Breaks in Peripheral Lymphocytes Exposed to Radiations from Iodine-131

  • 1. Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan (Iran, Islamic Republic of)
  • 2. Department of Medical Laboratory, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan (Iran, Islamic Republic of)
  • 3. Department of Biostatistics, Faculty of Health Sciences, Kashan University of Medical Sciences, Kashan (Iran, Islamic Republic of)
  • 4. Department of Nuclear Medicine, Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan (Iran, Islamic Republic of)

Description

Iodine-131 is used as a radiopharmaceutical to treat thyroid cancer. The current study aimed to evaluate the effects of vitamins E and C on the level of DNA double-strand breaks (DSBs) caused by Radioiodine-131 (I-131) in human lymphocytes. Whole blood samples from human volunteers were incubated with a certain concentration of vitamins. After 1-h incubation, the samples were incubated with 20 μCi I-131/2 mL (blood + NaCl) for 1 h. To evaluate the effects of antioxidants, lymphocytes were separated, and the mean DSBs/cell was measured for each sample through γ-H2AX assay. After 1-h incubation with 20 μCi I-131/2 mL (blood + NaCl), iodine-131 increased the level of DSBs by 102.9%, compared with the background group. Vitamins E and C reduced the level of DSBs by 21.5% and 36.4%, respectively. Using vitamins E and C as antioxidants can reduce the toxicity of I-131. Furthermore, vitamin C provided the more protection for DNA, compared with vitamin E.

Availability note (English)

Available from http://dx.doi.org/10.4103/ijnm.IJNM_89_17; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798093

Additional details

Identifiers

Publishing Information

Journal Title
Indian Journal of Nuclear Medicine
Journal Volume
33
Journal Issue
1
Journal Page Range
p. 20-24
ISSN
0972-3919

Optional Information

Notes
PMCID: PMC5798093; PMID: 29430110; PUBLISHER-ID: IJNM-33-20; OAI: oai:pubmedcentral.nih.gov:5798093; Copyright: (c) 2018 Indian Journal of Nuclear Medicine